Post

Conversation

Transcriptomic Profiling of Endothelial Progenitor Cells in Post-COVID-19 Patients: Insights at 3 and 6-Months Post-Infection 🔥SUSTAINED ENDOTHELIAL DAMAGE POST-C19 Very interesting follow-up Spanish study with the BAD news for today! ➡️Highlights: •Transcriptomic profiling reveals long-term endothelial dysfunction in post-COVID-19. •Enrichment analyses highlight disrupted pathways of endothelial homeostasis.Minimal changes between 3 and 6 months suggest sustained endothelial damage. •Post-COVID patients with PE display unique profiles with reduced thrombosis markers. ➡️"Overall, our findings identify differential expression patterns associated with disrupted endothelial cell functions in ECFCs derived from post-COVID-19 patients." ➡️"Our findings corroborate and expand upon existing evidence of endothelial dysfunction in COVID-19 patients, demonstrating decreased angiogenesis capacity, increased apoptosis, and oxidative stress." ➡️"This confirms persistent endothelial damage after recovery and may help explain certain pathological events observed in these individuals’ months or even years after infection." ‼️As we’ve said this many times before, the acute C19 phase isn’t your big problem anymore, it’s the post-infectious period, the bodily scars C19 leaves that you need to worry about! AVOID SARSCOV2/REINFECTIONS! sciencedirect.com/science/articl
Infographic divided into three main panels. First panel compares healthy controls and post-COVID patients with and without pulmonary embolism at 3 and 6 months, showing icons of human figures and lungs. Second panel illustrates workflow from blood sample to endothelial colony forming cells, RNA extraction, and sequencing with lab equipment depictions. Third panel displays bioinformatics results including mapping, differential expression volcano plot, Reactome pathway analysis for COVID-19, and various graphs like bubble plots, heatmaps, and bar charts on gene expressions, endothelial dysfunction, and cell growth.